domperidone and vasoactive intestinal peptide

domperidone has been researched along with vasoactive intestinal peptide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mogg, RJ; Samson, WK1
Arey, BJ; Freeman, ME1
Dominguez, JR; López, FJ; Negro-Vilar, A; Sánchez-Franco, F1
Gala, RR; Haisenleder, DJ; Lawson, DM; Moy, JA2
Conti, A; Faglia, G; Muratori, M; Togni, E; Travaglini, P1
Abbott, CR; Bloom, SR; Ghatei, MA; Kim, MS; Morgan, DG; Murphy, KG; Russell, SH; Small, CJ; Taheri, S; Todd, JF1

Other Studies

7 other study(ies) available for domperidone and vasoactive intestinal peptide

ArticleYear
Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Endocrinology, 1990, Volume: 126, Issue:2

    Topics: Animals; Domperidone; Dopamine; Dopamine Antagonists; Hypothalamus; Kinetics; Male; Neuropeptides; Oxytocin; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Vasoactive Intestinal Peptide

1990
Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion.
    Endocrinology, 1989, Volume: 124, Issue:2

    Topics: Animals; Domperidone; Female; Fenclonine; Hypothalamus; Ovariectomy; Oxytocin; Periodicity; Prolactin; Rats; Rats, Inbred Strains; Serotonin; Vasoactive Intestinal Peptide

1989
Role of dopamine and vasoactive intestinal peptide in the control of pulsatile prolactin secretion.
    Endocrinology, 1989, Volume: 124, Issue:1

    Topics: Animals; Domperidone; Dopamine; Haloperidol; Immunization, Passive; Male; Periodicity; Pimozide; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vasoactive Intestinal Peptide

1989
The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
    Endocrinology, 1986, Volume: 119, Issue:5

    Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Female; Hysterectomy; Prolactin; Pseudopregnancy; Rats; Thyrotropin-Releasing Hormone; Time Factors; Vasoactive Intestinal Peptide

1986
The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1988, Volume: 187, Issue:3

    Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Drug Synergism; Estradiol; Female; Ovariectomy; Progesterone; Prolactin; Rats; Rats, Inbred Strains; Sulpiride; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide

1988
Vasoactive intestinal polypeptide and dopamine: effect on prolactin secretion in normal women and patients with microprolactinomas.
    Neuroendocrinology, 1987, Volume: 46, Issue:3

    Topics: Adolescent; Adult; Domperidone; Dopamine; Female; Humans; Pituitary Neoplasms; Prolactin; Vasoactive Intestinal Peptide

1987
Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Journal of neuroendocrinology, 2000, Volume: 12, Issue:12

    Topics: Animals; Carrier Proteins; Cells, Cultured; Corticotropin-Releasing Hormone; Domperidone; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Hypothalamus; In Vitro Techniques; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Luteinizing Hormone; Male; Neuropeptides; Neurotensin; Orexin Receptors; Orexins; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Somatostatin; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide

2000